IBDEI1FM ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,23161,1,3,0)
;;=3^Acrodermatitis continua
;;^UTILITY(U,$J,358.3,23161,1,4,0)
;;=4^L40.2
;;^UTILITY(U,$J,358.3,23161,2)
;;=^5009162
;;^UTILITY(U,$J,358.3,23162,0)
;;=L40.3^^78^1003^29
;;^UTILITY(U,$J,358.3,23162,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23162,1,3,0)
;;=3^Pustulosis palmaris et plantaris
;;^UTILITY(U,$J,358.3,23162,1,4,0)
;;=4^L40.3
;;^UTILITY(U,$J,358.3,23162,2)
;;=^5009163
;;^UTILITY(U,$J,358.3,23163,0)
;;=L40.4^^78^1003^25
;;^UTILITY(U,$J,358.3,23163,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23163,1,3,0)
;;=3^Psoriasis,Guttate
;;^UTILITY(U,$J,358.3,23163,1,4,0)
;;=4^L40.4
;;^UTILITY(U,$J,358.3,23163,2)
;;=^5009164
;;^UTILITY(U,$J,358.3,23164,0)
;;=L40.8^^78^1003^26
;;^UTILITY(U,$J,358.3,23164,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23164,1,3,0)
;;=3^Psoriasis,Other
;;^UTILITY(U,$J,358.3,23164,1,4,0)
;;=4^L40.8
;;^UTILITY(U,$J,358.3,23164,2)
;;=^271917
;;^UTILITY(U,$J,358.3,23165,0)
;;=L72.3^^78^1003^31
;;^UTILITY(U,$J,358.3,23165,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23165,1,3,0)
;;=3^Sebaceous cyst
;;^UTILITY(U,$J,358.3,23165,1,4,0)
;;=4^L72.3
;;^UTILITY(U,$J,358.3,23165,2)
;;=^5009281
;;^UTILITY(U,$J,358.3,23166,0)
;;=L97.919^^78^1003^21
;;^UTILITY(U,$J,358.3,23166,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23166,1,3,0)
;;=3^Non-pressure chr ulcer unspec part right lower leg
;;^UTILITY(U,$J,358.3,23166,1,4,0)
;;=4^L97.919
;;^UTILITY(U,$J,358.3,23166,2)
;;=^5133688
;;^UTILITY(U,$J,358.3,23167,0)
;;=L97.929^^78^1003^20
;;^UTILITY(U,$J,358.3,23167,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23167,1,3,0)
;;=3^Non-pressure chr ulcer unspec part left lower leg
;;^UTILITY(U,$J,358.3,23167,1,4,0)
;;=4^L97.929
;;^UTILITY(U,$J,358.3,23167,2)
;;=^5133689
;;^UTILITY(U,$J,358.3,23168,0)
;;=L98.499^^78^1003^19
;;^UTILITY(U,$J,358.3,23168,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23168,1,3,0)
;;=3^Non-pressure chr skin ulcer
;;^UTILITY(U,$J,358.3,23168,1,4,0)
;;=4^L98.499
;;^UTILITY(U,$J,358.3,23168,2)
;;=^5009591
;;^UTILITY(U,$J,358.3,23169,0)
;;=L98.9^^78^1003^33
;;^UTILITY(U,$J,358.3,23169,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23169,1,3,0)
;;=3^Skin/Subcutaneous tissue disorder, unspec
;;^UTILITY(U,$J,358.3,23169,1,4,0)
;;=4^L98.9
;;^UTILITY(U,$J,358.3,23169,2)
;;=^5009595
;;^UTILITY(U,$J,358.3,23170,0)
;;=L20.81^^78^1003^15
;;^UTILITY(U,$J,358.3,23170,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23170,1,3,0)
;;=3^Dermatitis,Atopic
;;^UTILITY(U,$J,358.3,23170,1,4,0)
;;=4^L20.81
;;^UTILITY(U,$J,358.3,23170,2)
;;=^5009108
;;^UTILITY(U,$J,358.3,23171,0)
;;=L23.81^^78^1003^7
;;^UTILITY(U,$J,358.3,23171,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23171,1,3,0)
;;=3^Dermatitis,Allergic Contact,Animal Dander
;;^UTILITY(U,$J,358.3,23171,1,4,0)
;;=4^L23.81
;;^UTILITY(U,$J,358.3,23171,2)
;;=^5009123
;;^UTILITY(U,$J,358.3,23172,0)
;;=L23.2^^78^1003^8
;;^UTILITY(U,$J,358.3,23172,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23172,1,3,0)
;;=3^Dermatitis,Allergic Contact,Cosmetics
;;^UTILITY(U,$J,358.3,23172,1,4,0)
;;=4^L23.2
;;^UTILITY(U,$J,358.3,23172,2)
;;=^5009117
;;^UTILITY(U,$J,358.3,23173,0)
;;=L23.3^^78^1003^9
;;^UTILITY(U,$J,358.3,23173,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23173,1,3,0)
;;=3^Dermatitis,Allergic Contact,Drugs on Skin
;;^UTILITY(U,$J,358.3,23173,1,4,0)
;;=4^L23.3
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1FM 3791 printed Sep 23, 2025@19:43:47 Page 2
IBDEI1FM ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,23161,1,3,0)
+2 ;;=3^Acrodermatitis continua
+3 ;;^UTILITY(U,$J,358.3,23161,1,4,0)
+4 ;;=4^L40.2
+5 ;;^UTILITY(U,$J,358.3,23161,2)
+6 ;;=^5009162
+7 ;;^UTILITY(U,$J,358.3,23162,0)
+8 ;;=L40.3^^78^1003^29
+9 ;;^UTILITY(U,$J,358.3,23162,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,23162,1,3,0)
+12 ;;=3^Pustulosis palmaris et plantaris
+13 ;;^UTILITY(U,$J,358.3,23162,1,4,0)
+14 ;;=4^L40.3
+15 ;;^UTILITY(U,$J,358.3,23162,2)
+16 ;;=^5009163
+17 ;;^UTILITY(U,$J,358.3,23163,0)
+18 ;;=L40.4^^78^1003^25
+19 ;;^UTILITY(U,$J,358.3,23163,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,23163,1,3,0)
+22 ;;=3^Psoriasis,Guttate
+23 ;;^UTILITY(U,$J,358.3,23163,1,4,0)
+24 ;;=4^L40.4
+25 ;;^UTILITY(U,$J,358.3,23163,2)
+26 ;;=^5009164
+27 ;;^UTILITY(U,$J,358.3,23164,0)
+28 ;;=L40.8^^78^1003^26
+29 ;;^UTILITY(U,$J,358.3,23164,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,23164,1,3,0)
+32 ;;=3^Psoriasis,Other
+33 ;;^UTILITY(U,$J,358.3,23164,1,4,0)
+34 ;;=4^L40.8
+35 ;;^UTILITY(U,$J,358.3,23164,2)
+36 ;;=^271917
+37 ;;^UTILITY(U,$J,358.3,23165,0)
+38 ;;=L72.3^^78^1003^31
+39 ;;^UTILITY(U,$J,358.3,23165,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,23165,1,3,0)
+42 ;;=3^Sebaceous cyst
+43 ;;^UTILITY(U,$J,358.3,23165,1,4,0)
+44 ;;=4^L72.3
+45 ;;^UTILITY(U,$J,358.3,23165,2)
+46 ;;=^5009281
+47 ;;^UTILITY(U,$J,358.3,23166,0)
+48 ;;=L97.919^^78^1003^21
+49 ;;^UTILITY(U,$J,358.3,23166,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,23166,1,3,0)
+52 ;;=3^Non-pressure chr ulcer unspec part right lower leg
+53 ;;^UTILITY(U,$J,358.3,23166,1,4,0)
+54 ;;=4^L97.919
+55 ;;^UTILITY(U,$J,358.3,23166,2)
+56 ;;=^5133688
+57 ;;^UTILITY(U,$J,358.3,23167,0)
+58 ;;=L97.929^^78^1003^20
+59 ;;^UTILITY(U,$J,358.3,23167,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,23167,1,3,0)
+62 ;;=3^Non-pressure chr ulcer unspec part left lower leg
+63 ;;^UTILITY(U,$J,358.3,23167,1,4,0)
+64 ;;=4^L97.929
+65 ;;^UTILITY(U,$J,358.3,23167,2)
+66 ;;=^5133689
+67 ;;^UTILITY(U,$J,358.3,23168,0)
+68 ;;=L98.499^^78^1003^19
+69 ;;^UTILITY(U,$J,358.3,23168,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,23168,1,3,0)
+72 ;;=3^Non-pressure chr skin ulcer
+73 ;;^UTILITY(U,$J,358.3,23168,1,4,0)
+74 ;;=4^L98.499
+75 ;;^UTILITY(U,$J,358.3,23168,2)
+76 ;;=^5009591
+77 ;;^UTILITY(U,$J,358.3,23169,0)
+78 ;;=L98.9^^78^1003^33
+79 ;;^UTILITY(U,$J,358.3,23169,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,23169,1,3,0)
+82 ;;=3^Skin/Subcutaneous tissue disorder, unspec
+83 ;;^UTILITY(U,$J,358.3,23169,1,4,0)
+84 ;;=4^L98.9
+85 ;;^UTILITY(U,$J,358.3,23169,2)
+86 ;;=^5009595
+87 ;;^UTILITY(U,$J,358.3,23170,0)
+88 ;;=L20.81^^78^1003^15
+89 ;;^UTILITY(U,$J,358.3,23170,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,23170,1,3,0)
+92 ;;=3^Dermatitis,Atopic
+93 ;;^UTILITY(U,$J,358.3,23170,1,4,0)
+94 ;;=4^L20.81
+95 ;;^UTILITY(U,$J,358.3,23170,2)
+96 ;;=^5009108
+97 ;;^UTILITY(U,$J,358.3,23171,0)
+98 ;;=L23.81^^78^1003^7
+99 ;;^UTILITY(U,$J,358.3,23171,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,23171,1,3,0)
+102 ;;=3^Dermatitis,Allergic Contact,Animal Dander
+103 ;;^UTILITY(U,$J,358.3,23171,1,4,0)
+104 ;;=4^L23.81
+105 ;;^UTILITY(U,$J,358.3,23171,2)
+106 ;;=^5009123
+107 ;;^UTILITY(U,$J,358.3,23172,0)
+108 ;;=L23.2^^78^1003^8
+109 ;;^UTILITY(U,$J,358.3,23172,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,23172,1,3,0)
+112 ;;=3^Dermatitis,Allergic Contact,Cosmetics
+113 ;;^UTILITY(U,$J,358.3,23172,1,4,0)
+114 ;;=4^L23.2
+115 ;;^UTILITY(U,$J,358.3,23172,2)
+116 ;;=^5009117
+117 ;;^UTILITY(U,$J,358.3,23173,0)
+118 ;;=L23.3^^78^1003^9
+119 ;;^UTILITY(U,$J,358.3,23173,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,23173,1,3,0)
+122 ;;=3^Dermatitis,Allergic Contact,Drugs on Skin
+123 ;;^UTILITY(U,$J,358.3,23173,1,4,0)
+124 ;;=4^L23.3
